D.E. Shaw & Co’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$138K Buy
+44,856
New +$194K ﹤0.01% 4251
2025
Q1
Sell
-105,130
Closed -$1.13M 4243
2024
Q4
$1.13M Buy
+105,130
New +$809K ﹤0.01% 3133
2024
Q3
Sell
-58,355
Closed -$246K 4526
2024
Q2
$246K Sell
58,355
-11,263
-16% -$45.6K ﹤0.01% 3991
2024
Q1
$354K Buy
69,618
+16,164
+30% +$91K ﹤0.01% 3651
2023
Q4
$498K Buy
53,454
+20,913
+64% +$144K ﹤0.01% 3515
2023
Q3
$213K Sell
32,541
-12,563
-28% -$100K ﹤0.01% 3737
2023
Q2
$367K Buy
+45,104
New +$387K ﹤0.01% 3536
2023
Q1
Sell
-46,190
Closed -$428K 4423
2022
Q4
$428K Sell
46,190
-257,959
-85% -$2.76M ﹤0.01% 3939
2022
Q3
$3.14M Sell
304,149
-73,205
-19% -$773K ﹤0.01% 2593
2022
Q2
$3.78M Buy
377,354
+67,962
+22% +$644K ﹤0.01% 2474
2022
Q1
$3.81M Buy
309,392
+292,864
+1,772% +$3.6M ﹤0.01% 2636
2021
Q4
$287K Sell
16,528
-28,351
-63% -$539K ﹤0.01% 4697
2021
Q3
$806K Sell
44,879
-54,814
-55% -$1.09M ﹤0.01% 3772
2021
Q2
$2.28M Buy
99,693
+48,244
+94% +$715K ﹤0.01% 2811
2021
Q1
$769K Buy
+51,449
New +$562K ﹤0.01% 3288
2020
Q3
Sell
-31,195
Closed -$153K 3823
2020
Q2
$153K Sell
31,195
-29,563
-49% -$112K ﹤0.01% 3835
2020
Q1
$191K Sell
60,758
-10,792
-15% -$37.6K ﹤0.01% 3659
2019
Q4
$185K Buy
+71,550
New +$188K ﹤0.01% 3817
2019
Q3
Sell
-35,587
Closed -$120K 3800
2019
Q2
$120K Buy
+35,587
New +$111K ﹤0.01% 3533
2018
Q1
Sell
-16,140
Closed -$52K 3478
2017
Q4
$52K Buy
+16,140
New +$63.5K ﹤0.01% 3532
2016
Q4
Sell
-119,534
Closed -$434K 3421
2016
Q3
$434K Buy
119,534
+105,080
+727% +$442K ﹤0.01% 2866
2016
Q2
$88K Buy
+14,454
New +$69.8K ﹤0.01% 3266

Other funds holding AVXL